Maintenance Olaparib Found to Provide a PFS Benefit in Advanced Ovarian Cancer
The benefit was seen in an all-comers population, according to the presenters at ESMO Congress 2019.
Ovarian Cancer
Oophorectomy More Effective Than Ultrasound Screening in Preventing BRCA1-Related Ovarian Cancer
Results of a prospective study comparing effectiveness of ultrasound screening and salpingo-oophorectomy in preventing ovarian cancer are presented.
Dual-Targeted CAR-T Therapies in Solid Tumors: Q&A With Dr Wayne Marasco
Dr Marasco explains that CAR-T therapies are really “cellular therapies that work by way of gene manipulation,” and describes a method through which he hopes CAR-T can produce durable, long-term treatments for solid tumors.
Intrauterine Device Use May Reduce Incidence of Ovarian Cancer
Novel noncontraceptive benefit seen for all intrauterine devices.
Pain Associated With Quality of Life and Survival for Patients With Recurrent Ovarian Cancer
Researchers sought to analyze how pain management affects quality of life and overall survival for patients with recurrent ovarian cancer.
Germline BRCA2 Mutations Linked to Pediatric Lymphomas
Survivors of NHL should be offered genetic counseling.
Black Women With Cervical Cancer Less Likely to Receive Brachytherapy
Black women with cervical cancer were less likely to receive brachytherapy and had poorer survival, suggesting brachytherapy may mediate survival outcomes.
Zejula Gets Priority Review for Late Stage Ovarian Cancer Indication
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.
Research Shows How Talc Powder May Change Ovarian Cancer Cells
Prospective studies on talc and cancer are necessary to fully form our collective understanding of talc’s risks.
Boost in Frontline Bevacizumab Use in Ovarian Cancer Linked to Guidelines Inclusion
Addition of bevacizumab to NCCN guidelines as a frontline therapy in ovarian cancer spurred more utilization of the drug than did fresh findings from clinical trials.
Next post in Gynecologic Cancer
